The relevance of this question extends beyond the fragile X-associated disorders to other forms of neurodevelopmental and neuropsychiatric dysfunction, as exemplified by lowered FMRP levels in the brains of those with autism/ASD [70–72] and major psychiatric disorders, including depression and schizophrenia [73, 74]. The gene discussed is FMR1; the disease is psychiatric disorder.